Dr. Tucker has extensive senior leadership experience, having previously served as CEO, CFO and Vice President for several biotech companies, both publicly listed and privately held. He has taken companies from incorporation through to acquisition, out-licensing, and stock market listing. Dr. Tucker has raised millions in company funding through capital market equity financings and from non-dilutive funding sources. He holds more than 20 issued or pending patents, has a Ph.D. in Biochemistry and Molecular Biology from the University of Calgary, and is a member of the Board of Directors of BioAlberta.
Dr. Peter Facchini, CSO and co-founder
Dr. Facchini has been Professor of Plant Biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is also the Canada Research Chair in Plant Metabolic Processes Biotechnology. His research is focused on the biosynthesis and biotechnology of high-value metabolites in plants. His research program has been funded by numerous federal and provincial government agencies, and by various industrial partners. In 2003, he received the C.D. Nelson Award from the Canadian Society of Plant Physiologists as the outstanding young plant biologist in Canada. Among numerous media appearances, his work has been featured on the CBC National News, the Discovery Channel, the Globe and Mail and the National Post. He has published more than 130 research papers and scholarly articles, which appear regularly in high-impact journals such as Nature Chemical Biology, Plant Cell, Plant Journal and the Journal of Biological Chemistry. He obtained his Ph.D. from the University of Toronto in 1991, and conducted postdoctoral research at the University of Kentucky and the Université de Montréal.
Dr. Jillian Hagel, COO and co-founder
In her role as COO, Dr. Hagel guides research directions, reports to funding agencies, and works closely with industrial partners at the ground-level to successfully deploy Epimeron technology and meet client needs. Jill is a research associate in the Department of Biological Sciences at the University of Calgary with extensive grant-writing experience in both academic and commercial contexts. She has dedicated the past 15 years to the study of plant specialized metabolism, co-authored over 25 peer-reviewed publications in high-ranking journals such as Nature Chemical Biology and Plant Cell, and presented her work internationally. Her award-winning research led to her being chosen by Genome Canada as one of 30 young scientists to present their work nationally. She completed her PhD in 2010 at the University of Calgary.
SELECTED PAST ACHIEVEMENTS by EPIMERON LEADERSHIP
2007 Canada’s Top Ten Life Science Companies (Dr. Tucker)
2005 Nominated for E&Y Entrepreneur of the Year (Dr. Tucker)
2003 C.D. Nelson Award (outstanding young plant biologist in Canada), Canadian Society of Plant Physiologists (Dr. Facchini)
Notable Research discoveries:
Collectively, nearly 30 issued & pending patents
Isolation of key genes involved in the biosynthesis of the analgesics morphine and codeine, the anticancer drug noscapine, and the antimicrobial agent sanguinarine
Application of functional biochemical genomics in opium poppy and related alkaloid-producing plants, resulting in many ground-breaking discoveries
Selected Funding bodies:
Natural Sciences and Engineering Research Council of Canada
The Canada Foundation for Innovation
National Research Council – Industrial Research Assistance Program